Collegium Pharmaceutical, Inc.: dividend

COLLNASDAQHealthcare · Pharmaceutical Preparations

Price

$25.32

November 13, 2026Market cap $804M

DCF calculator

What Ploutos Investor adds for Collegium Pharmaceutical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 10 fiscal years, from 2016
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
  • Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.

Collegium Pharmaceutical pays no dividend

It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 3.12% of market cap in the latest fiscal year.

All dividend stocks

Everything it returns to shareholders

The dividend is one way. The other is buybacks, which reduce the number of shares.

Dividend yield

0.00%

Buybacks

3.12%

$31.20 a year per $1,000 of shares

The share count rose by 0.9% over the year, so more shares were issued than bought back.

Total returned

3.12%

$31.20 a year per $1,000 of shares

dividend 0%buybacks 100%

The full analysis

What do Collegium Pharmaceutical's filings show?

The dividend is one part of Collegium Pharmaceutical's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about COLL's dividend

Didn't find what you were looking for?

Ask us
Does COLL pay a dividend?

It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 3.12% of market cap in the latest fiscal year.

How does COLL return money to shareholders?

Collegium Pharmaceutical pays no dividend. Its buybacks in the latest fiscal year came to 3.12% of market cap.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.GlossaryEvery figure in plain words: what it is, how it is worked out, how to read it.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.